Michael Burry’s Top Holdings Were Gaining While NVDA Was Crashing

8. Bruker Corp

Portion of portfolio: 5.67%

Value of holdings: $4,396,500

Bruker Corp (NASDAQ: BRKR) is an American manufacturer of scientific instruments for molecular and materials research, as well as for industrial and applied analysis.

Burry opened a position in Bruker in the fourth quarter purchasing 75,000 of its shares.

The current market capitalization of Bruker is $6.912 billion, according to Yahoo Finance. The company recently reported adjusted earnings per share of $0.76 for the fourth quarter of 2024, above the analyst consensus of $0.74. Quarterly revenue totaled $979.6 million, up 14.6% year-over-year and exceeding estimates of $962.38 million. In 2025, Bruker expects to hit between $3.47 billion and $3.54 billion in revenue, representing growth of 3% to 5% year-over-year, according to Bruker’s SEC filing.

Bruker alongside Magnetic Ventures, individual investors, Josef Feldman, John Maraganore, Hans Bishop and John Evans provided Terrain Biosciences, Inc. with $9 million in a round of funding dated February 12.

On February 27, the company introduced the X4 POSEIDON, a new benchtop 3D X-ray microscope (XRM) system,  expected to deliver high-resolution imaging capabilities comparable to those of larger, floor-standing systems.

Year-to-date Bruker’s stock has lost 22.28% of its value and has traded at $45.56 on March 11, after the market close.